Riktkurs.nu
EN | SV
Stockholm Stock Exchange | Mid Cap
Biogaia
-7.95%
-
SEBHandelsbankenCarnegieHandelsbanken Capital Markets

Latest Price Target For Biogaia

Upside:
-7.95%
AnalystPrice TargetDate
SEB110 SEKOct -24

All Price Targets For Biogaia

SEB
Oct -24
-7.95%
+46.44%
Carnegie
May -24
+25.52%
+8.79%

About The Company

Biogaia AB is a Swedish biotechnology company that develops and sells probiotic products. Biogaia has been developed from research findings on the lactic acid bacterium Limosilactobacillus reuteri and the substance reuterin, which was carried out by Walter Dobrogosz and Sven Lindgren in the 1980s.
Wikipedia